# Bar Code Label Requirement for Human Drug Products and Biological Products; Correction
**AGENCY:**
Food and Drug Administration, HHS.
**ACTION:**
Final rule; correction.
**SUMMARY:**
The Food and Drug Administration (FDA) is correcting a final rule that appeared in the *Federal Register* of February 26, 2004 (69 FR 9120). The document included typographical and inadvertent errors. This document corrects those errors.
**FOR FURTHER INFORMATION CONTACT:**
Philip L. Chao, Office of Policy and Planning (HF-23), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-0587.
**SUPPLEMENTARY INFORMATION:**
In FR Doc. 04-4249, appearing on page 9120 in the *Federal Register* of Thursday, February 26, 2004, the following corrections are made:
**21 CFR Part 201**
1. On page 9151, in the third column, the first sentence of the first full paragraph, is corrected to read “We estimate that the rule provides net benefits to society of $4.3 billion to $4.5 billion annually, depending on whether a discount rate of 3 percent or 7 percent is used.”
2. On page 9167, in the first column, the first sentence under the heading “ *P. Small Business Analysis and Discussion of Alternatives* ” is corrected to read “For the reasons cited in the following paragraphs, the agency certifies that the final rule will not have a significant economic impact on a substantial number of small entities.”
Dated: March 31, 2004.
Jeffrey Shuren,
Assistant Commissioner for Policy.